KYOWA KIRIN
Kyowa Hakko Kirin Co is a Japanese pharmaceutical and biotechnology company that specializes in healthcare.
KYOWA KIRIN
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1949-07-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.kyowakirin.com
Total Employee:
11+
Status:
Active
Contact:
81 3-5205-7200
Technology used in webpage:
LetsEncrypt WordPress Font Awesome Apache Wordpress Plugins Mobile Non Scaleable Content Organization Schema Yoast WordPress SEO Plugin ReCAPTCHA Yoast SEO Premium
Similar Organizations
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Wockhardt Hospitals
Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.kyowakirin.com Semrush global rank: 1.35 M Semrush visits lastest month: 21.51 K
- Host name: ec2-18-179-126-206.ap-northeast-1.compute.amazonaws.com
- IP address: 18.179.126.206
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Kyowa Kirin"
Kyowa Kirin Announces Changes to its Organization
Dec 1, 2023 efficiency, while realizing an organization that continuously creates innovative therapies with life-changing value. Additionally, under the One Kyowa Kirin’s framework, which …See details»
Corporate Governance | Management | Investors
Mar 25, 2024 Introduction of Corporate Governance. The Company is carrying out its business activities ba sed on a philosophy that “ The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around …See details»
Our Leadership - Kyowa Kirin
Business Unit Leader, Specialty Health Organization; Next Generation Commercial Model Development; Eli Lilly and Company, USA. Jul. 2017: Senior Vice President, Business Unit …See details»
Kyowa Kirin - Wikipedia
Kyowa Kirin Co., Ltd. (協和キリン株式会社, Kyōwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index. See details»
Learn How Our Values Help Drive Global …
Prior to joining this organization, she was Vice President and Head Global Medical Affairs at Ventana/Roche Tissue Diagnostics. She is a physician with 10 years experience in clinical practice (internal medicine and …See details»
Kyowa Kirin North America Homepage, a Specialty …
Kyowa Kirin pursues scientific breakthroughs to address unmet clinical needs. Learn more about our portfolio of specialty medicines in nephrology, oncology, immunology & allergy, and neurology. Join us to grow your career or partner …See details»
Kyowa Kirin | Specialty Pharmaceuticals for Global …
Sep 3, 2024 Making People Smile For Generations To Come. Kyowa Kirin aims to discover and deliver novel medicines and treatments with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we have …See details»
Kyowa Kirin Integrates North America Businesses in Support of …
Mar 31, 2021 The outcome of this merger is a simpler business structure for the organization and a common set of processes and systems to enhance the productivity and collaborations …See details»
Kyowa Kirin Announces Changes to its Organization
Kyowa Kirin Announces Changes to its Organization Tokyo, Japan, August 26, 2022 – Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto, “Kyowa Kirin”, TSE: 4151) announced …See details»
Kyowa Kirin Value: Delivering Life-Changing Value in …
Our Commitment to Life means that we are focussing our efforts to improve the quality of life for patients around the world. Our agile and purposeful structure enables us to focus our efforts on where we can have the greatest impact, and …See details»
Kyowa Kirin, Inc.- U.S. | LinkedIn
Kyowa Kirin, Inc.- U.S. Pharmaceutical Manufacturing Princeton, New Jersey 30,304 followers Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a …See details»
Kyowa Kirin Designs New North American Headquarters to …
Jul 11, 2023 Japan-Based Specialty Pharmaceutical Company Moves Into Princeton, NJ, Offices Princeton, N.J. – July 11, 2023 – Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. …See details»
Kyowa Kirin Announces Changes to its Organization
Miyamoto, “Kyowa Kirin”, TSE: 4151) announced that it will make changes to its organization as of April 1, 2021. Outline of the changes: 1) Strategic Product Planning Department will be split …See details»
Kyowa Kirin Canada | Kyowa Kirin North America
By clicking the Send button, you authorize Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents to contact you by mail and/or email to provide information on products, programs, …See details»
Kyowa Kirin Announces its Organizational Change
Organization as of July 1, 2021. Outline of the change: R&D Quality Assurance Department will be newly established within the Quality Division. Purpose of the organizational change: By …See details»
Kyowa Kirin - Overview, News & Similar companies - ZoomInfo
Apr 11, 2023 View Kyowa Kirin (kkna.kyowakirin.com) location in New Jersey, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Kyowa Kirin North America Announces Key Executive …
Deb has built a very strong North American Medical Affairs organization and I'm thrilled to partner with her, and the entire Global Medical Affairs community, to take our team even further as …See details»
Kyowa Kirin Announces Changes in Top Leadership Positions to …
Oct 31, 2024 Masashi Miyamoto to be named Chairman and CEO Abdul Mullick to be named President and COO Changes designed to further deliver on company’s 2030 Vision and …See details»
Media Center - Kyowa Kirin
The global speciality pharmaceutical innovator, Kyowa Kirin makes drugs that make headlines. The company’s rich pipeline contains candidate treatments for cancer, kidney disease, …See details»